Immunosuppressive therapy with oral prednisone to prevent restenosis after PCI. A multicenter randomized trial

Flavio Ribichini, Fabrizio Tomai, Giuseppe De Luca, Giacomo Boccuzzi, Patrizia Presbitero, Gabriele Pesarini, Valeria Ferrero, Anna S. Ghini, Ramadan Abukaresh, Cristina Aurigemma, Leonardo De Luca, Dennis Zavalloni, Daniela Soregaroli, Paolo Marino, Roberto Garbo, Luisa Zanolla, Corrado Vassanelli

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Prednisone at immunosuppressive doses after stenting has shown remarkable efficacy in reducing ischemic recurrences in nondiabetic patients with high post-procedural levels of C-reactive protein; the study aim was to compare the clinical outcome obtained in a control group of patients treated with bare metal stents versus 2 other study groupsbare metal stent plus oral prednisone or drug eluting stentsassuming similar optimal adjunctive medical treatment. Methods: Five tertiary Italian hospitals enrolled 375 nondiabetic patients with coronary artery disease and no contraindications to dual antiplatelet treatment or corticosteroid therapy in a randomized, controlled study performed between 2007 and 2009. Patients were allocated into 3 study groups: bare metal stents (controls), bare metal stents followed by a 40-day prednisone treatment, or drug-eluting stents. The primary endpoint was the event-free survival of cardiovascular death, myocardial infarction, and recurrence of ischemia needing repeated target vessel revascularization at 1 year as adjudicated by an independent clinical events committee. Results: One-year follow-up was obtained in all patients. Patients receiving bare metal stents alone as compared to those treated with prednisone or drug-eluting stents had lower event-free survival; the primary endpoint was 80.8% in controls compared to 88.0% in the prednisone and 88.8% in the drug-eluting stent groups, respectively (P = .04 and .006). Conclusion: Compared with bare metal stents alone, prednisone treatment after bare metal stents or drug-eluting stent implantation result in a better event-free survival at 1 year.

Original languageEnglish
Pages (from-to)434-443
Number of pages10
JournalAmerican Journal of Medicine
Volume124
Issue number5
DOIs
Publication statusPublished - May 2011

Keywords

  • Coronary artery disease
  • Prednisone
  • Randomized clinical trial
  • Stent

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Immunosuppressive therapy with oral prednisone to prevent restenosis after PCI. A multicenter randomized trial'. Together they form a unique fingerprint.

Cite this